Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Tapering in Sarcoidosis
NCT07498842Recruiting
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone in sarcoidosis (2 arms), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Proportion of patients achieving a prednisolone dose < 50% of baseline dose. Started Mar 2026; status: recruiting.
02
Drugs
prednisolone
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NCT07498842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498842.